Speaking
I speak about psychedelic medicine, clinical infrastructure, and the Nordic model for integrating new psychiatric treatments into public healthcare.
A decade of clinical insights: real-world evidence from European ketamine clinics
Panel presenting real-world evidence from a decade of European ketamine clinics. Moderated by Rutger Engels, with Filip Tylš, Andrea Jungaberle and Tomáš Páleníček. Event: https://www.icpr-conference.com/programme/a-decade-of-clinical-insights-real-world-evidence-from-european-ketamine-clinics-recgysh
From TMS to Psychedelics: Building Europe's Interventional Psychiatry Future
Panel on the evolution of interventional psychiatry, from neuromodulation approaches such as TMS to emerging psychedelic-assisted therapies, and what is required for clinical adoption, regulation, and system integration in Europe. Moderated by Josh Hardman (Psychedelic Alpha), with Kathy Xiang (COMPASS Pathways) and Dr James Stefaniak (North London NHS Foundation Trust). Event: https://www.thereal.events/london-2026
European Forum of National Psychedelic Societies
Guest speaker at PAREA's closed, invitation-only forum bringing together national psychedelic-society representatives from across Europe, focused on early access pathways, regulation, and implementation within public healthcare systems. Lowan contributed on Norway's nationwide public reimbursement of ketamine treatment and implementing access in public healthcare. Event: https://parea.eu/events/forum-2026
Ketamine: The Psychedelic Elephant in the Room
History, phenomenology, mechanisms and evolution of ketamine use in treatment of mental health disorders.
Research update and reflections on the psychedelic field
Ketamine for the treatment of addiction
Keynote lecture on what ketamine is, how it works, its therapeutic applications for addiction.
Alle mann til pumpene! Dosering, titrering og vedlikehold
Practical session on ketamine dosing, titration and maintenance for physicians and leaders. Co-presented with Rupert McShane (University of Oxford).
Ketamine in a Therapeutic Setting as Treatment for Alcohol/Substance Use Disorder
Panel on using ketamine to treat substance use disorder.
Ketamine-assisted psychotherapy for alcohol use disorder and other addictions
Q&A panel with Norwegian Psychedelic Therapists and Scientists
Ketamine for the treatment of substance use disorders
Ketamine for Depression and Reconnection
Ketamin vid depression och kronisk smärta
Ketamine: Treating depression and addiction
PHA Fredagsmøte guest lecture
Guest lecture for the Psychedelic Health & Addiction group.